Minimally Invasive Lumbar Decompression and Removal of Symptomatic Heterotopic Bone Formation After Spinal Fusion with Recombinant Human Bone Morphogenetic Protein-2.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 32387785.
- Also identified by DOI 10.1016/j.wneu.2020.04.235 and PMC identifier 7202823.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We present a case of symptomatic heterotopic bone formation following revision of posterolateral lumbar fusion/instrumentation and "off-label" use of recombinant human bone morphogenetic protein-2, treated successfully with the use of a minimally invasive tubular approach.
Medical subject headings
- Bone Morphogenetic Protein 2
- Lumbar Vertebrae
- Ossification, Heterotopic
- Spinal Fusion
- Transforming Growth Factor beta